Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Citius Pharmaceuticals stock
Own Citius Pharmaceuticals stock in just a few minutes.
Citius Pharmaceuticals, Inc is a biotechnology business based in the US. Citius Pharmaceuticals shares (CTXR) are listed on the NASDAQ and all prices are listed in US Dollars. Citius Pharmaceuticals employs 10 staff and has a market cap (total outstanding shares value) of USD0.00.
How to buy shares in Citius Pharmaceuticals
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Citius Pharmaceuticals. Find the stock by name or ticker symbol: CTXR. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Citius Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Citius Pharmaceuticals, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Citius Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Citius Pharmaceuticals share price
Use our graph to track the performance of CTXR stocks over time.Citius Pharmaceuticals shares at a glance
Information last updated 2021-04-15.
| 52-week range | USD$0.64 - USD$2.50 |
|---|---|
| 50-day moving average | USD$1.90 |
| 200-day moving average | USD$1.34 |
| Wall St. target price | USD$6.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.82 |
Buy Citius Pharmaceuticals shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Citius Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Citius Pharmaceuticals financials
| Gross profit TTM | USD$0 |
|---|---|
| Return on assets TTM | -44.4% |
| Return on equity TTM | -92.57% |
| Profit margin | 0% |
| Book value | $0.45 |
| Market capitalisation | USD$232.9 million |
TTM: trailing 12 months
Shorting Citius Pharmaceuticals shares
There are currently 11.0 million Citius Pharmaceuticals shares held short by investors – that's known as Citius Pharmaceuticals's "short interest". This figure is 51.3% up from 7.3 million last month.
There are a few different ways that this level of interest in shorting Citius Pharmaceuticals shares can be evaluated.
Citius Pharmaceuticals's "short interest ratio" (SIR)
Citius Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Citius Pharmaceuticals shares currently shorted divided by the average quantity of Citius Pharmaceuticals shares traded daily (recently around 10.1 million). Citius Pharmaceuticals's SIR currently stands at 1.09. In other words for every 100,000 Citius Pharmaceuticals shares traded daily on the market, roughly 1090 shares are currently held short.
However Citius Pharmaceuticals's short interest can also be evaluated against the total number of Citius Pharmaceuticals shares, or, against the total number of tradable Citius Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Citius Pharmaceuticals's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Citius Pharmaceuticals shares in existence, roughly 80 shares are currently held short) or 0.0902% of the tradable shares (for every 100,000 tradable Citius Pharmaceuticals shares, roughly 90 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Citius Pharmaceuticals.
Find out more about how you can short Citius Pharmaceuticals stock.
Citius Pharmaceuticals share dividends
We're not expecting Citius Pharmaceuticals to pay a dividend over the next 12 months.
Have Citius Pharmaceuticals's shares ever split?
Citius Pharmaceuticals's shares were split on a 1:15 basis on 8 June 2017. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Citius Pharmaceuticals shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Citius Pharmaceuticals shares which in turn could have impacted Citius Pharmaceuticals's share price.
Citius Pharmaceuticals share price volatility
Over the last 12 months, Citius Pharmaceuticals's shares have ranged in value from as little as $0.64 up to $2.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Citius Pharmaceuticals's is 1.5378. This would suggest that Citius Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Citius Pharmaceuticals overview
Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. .
Frequently asked questions
More guides on Finder
-
How to buy ZTO Express Cayman stock
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
-
How to buy Zomedica stock
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
-
How to buy ZoomInfo Technologies stock
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
-
How to buy ZK International Group CoLtd stock
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
-
How to buy Zions Bancorporation National Association stock
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
-
How to buy ZIONL stock
Steps to owning and managing ZIONL, with 24-hour and historical pricing before you buy.
-
How to buy Zentalis Pharmaceuticals stock
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
-
How to buy Yunhong International stock
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
-
How to buy Zealand Pharma A/S stock
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
-
How to buy Yunhong CTI stock
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.
Ask an Expert